800-401-4720
Recent Posts
Categories
Archives
Dangerous Drugs
Injuries
Contact Us
Dangerous Drugs and Injuiries Attorneys
Dangerous Drugs and Injuries Lawyers Who We Are What We Do Frequently Asked Questions Contact Us
We Sue Companies That Sell Dangerous Drugs
Nationwide Law Practice click here to be instantly connected to our office Medical and Legal News
« European Health Agency to Label Gadolinium-Based Contrast Agents as High-, Medium-, or Low-Risk for Causing NSF | Main  | 8th Circuit Removes Roadblock for Ocella Injury Lawsuits »
  Gadolinium-Based Contrast Agents Speed Multiple Myeloma Cell Growth
A paper presented at the recent annual convention of the American Society of Hematology reported that exposure to the gadolinium-based contrast agent Omniscan, manufactured by GE Healthcare, speeds the growth of multiple myeloma cells.

Multiple myeloma is a cancer of the white blood cells. MRIs enhanced with gadolinium-based contrast agents are frequently used to image bone marrow, where white blood cells are produced. The researchers found that multiple myeloma cell growth rates were 8-20 times greater after exposure to Ominiscan, depending on the size and frequency of Omniscan exposure.

Significantly, autopsies of eight multiple myeloma patients who had repeated exposures to Omniscan revealed “massive quantities of gadolinium accumulation in tissues” regardless of renal function. This is particularly troubling. The current understanding is that people with impaired renal function are at the greatest risk of the gadolinium ion breaking free from the contrast agent and depositing in their bodies because their kidneys are unable to remove the agent from their bodies before it begins breaking down. These findings indicate that large amounts of gadolinium can be deposited in the body even if a person’s kidneys are functioning normally.

Gadolinium is a rare earth element long known to be toxic to human tissue. Gadolinium-based contrast agents, used for medical scans such as MRI and MRA, cause Nephrogenic Systemic Fibrosis (“NSF”). NSF is a progressive, incurable disease characterized by hardening of the skin and other body tissues. Dialysis patients are most at risk of developing NSF. If you or someone you know has NSF, you may have a legal claim against the manufacturer of the gadolinium-based contrast agent that caused the disease. Contract the NSF lawyers/MRI attorneys at DeCarli Law for a free consultation.

Posted By DeCarli Law on January 06, 2010 10:35 am | Permalink 

Comments

No Comments Posted
Attorney Web Design The information on this website is for general information purposes only. Nothing on this or associated pages, documents, comments, answers, emails, or other communications should be taken as legal advice for any individual case or situation. The information on this website is not intended to create, and receipt or viewing of this information does not constitute, an attorney-client relationship. DeCarli Law only represents individuals pursuant to a signed, written contract.

Address: 50 California Street, Suite 1500 San Francisco CA 94111 Toll Free: 1-800-401-4720 Phone: 1-415-738-6144
Debra DeCarli and Bob DeCarli are licensed by the State Bar of Texas and the State Bar of California.

DeCarli Law represents drug side effects and defective medical devices personal injury clients for claims, lawsuits and settlements in Alabama AL, Alaska AK, Arizona AZ, Arkansas AR, California CA, Colorado CO, Connecticut CT, Delaware DE, Georgia GA, Hawaii HI, Idaho ID, Illinois IL, Kansas KS, Maine ME, Maryland MD, Massachusetts MS, Minnesota MN, Mississippi MS, Montana MT, Nebraska NE, New Hampshire NH, New Jersey NJ, New Mexico NM, New York NY, North Carolina NC, North Dakota ND, Oklahoma OK, Oregon OR, Rhode Island RI, South Carolina SC, South Dakota SD, Tennessee TN, Utah UT, Vermont VT, Virginia VA, Washington WA, Washington D.C, West Virginia WV, Wisconsin WI and Wyoming WY. The attorneys of DeCarli Law are licensed in California and Texas. DeCarli Law's practice includes lawsuits for Propecia side effects, Finasteride lawsuits, Topamax lawsuits, Fosamax lawsuits, Gadolinium lawsuits, NSF lawsuits, Nephrogenic Systemic Fibrosis Lawsuits, YAZ lawsuits, Yasmin lawsuits, Ocella lawsuits, and Zarah lawsuits.